Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.94 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/24/15 All times are local (Market data is delayed by at least 15 minutes).

pharma-bio serv inc (PBSV) Key Developments

Pharma-Bio Serv, Inc. Reports Earnings Results for the Three and Six Months Ended April 30, 2015

Pharma-Bio Serv, Inc. reported earnings results for the three and six months ended April 30, 2015. For the second quarter, net revenue was $5.4 million a decrease of approximately $1.1 or 17.2% respectively, when compared to the same periods last year. Net income was approximately $0.4 no significant Variance when compared with the same periods last year. Earnings  per common share diluted  for the three months  ended April 30, 2015 was $0.015. These represents an increase of $0.001 per diluted share  for the three months ended  April 30, 2015. For the six months, net revenues of $11.3 million, respectively, a decrease of approximately $2.3 million or 16.6%, respectively, when compared to the same periods last year. The revenue decrease is mainly attributable to declines in the United States and Europe consulting markets of $1.4 and $0.2 million, and $2.9 and $0.5, for the three months and six months ended April 30, 2015, as compared to the same periods last year respectively, partially offset by gains in the Puerto Rico consulting business of $0.6 and $1.3 million, respectively. Net income was approximately $0.6 million a decrease of $0.3 million for the six months ended April 30, 2015, when compared with the same periods last year. Net income variance is mainly attributable to the decline in revenue, partially offset by a reduction of business development and operational support expenses, and the effect of the effective income tax rates (including Puerto Rico favorable tax grants) over income before tax. Earnings  per common share diluted  for the six months  ended April 30, 2015 were $0.028.  These represents a decrease $1.014  per common  diluted share,  for the six  months ended  April 30, 2015.

Pharma-Bio Serv, Inc. Presents at SeeThruEquity 4th Annual MicroCap Investor Conference, May-28-2015 01:00 PM

Pharma-Bio Serv, Inc. Presents at SeeThruEquity 4th Annual MicroCap Investor Conference, May-28-2015 01:00 PM. Venue: Convene Grand Central, 101 Park Ave, New York, NY 10178, United States.

Pharma-Bio Serv, Inc., Annual General Meeting, May 01, 2015

Pharma-Bio Serv, Inc., Annual General Meeting, May 01, 2015., at 10:00 Eastern Daylight. Location: 545 West Germantown Pike. Agenda: To propose the election of two directors as Class II directors to serve for a term until the 2018 annual meeting of stockholders or until a successor is duly elected and qualified; to propose the ratification of the selection of Horwath Velez & Co. PSC as the company's independent certified public accountants for the fiscal year ending October 31, 2015; and to propose the transaction of such other and further business as may properly come before the meeting or any, adjournments or postponements of the meeting.

Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2015

Pharma-Bio Serv, Inc. reported earnings results for the first quarter ended January 31, 2015. For the quarter, the company reported net revenues for the three months ended January 31, 2015 were $5.9 million, a decrease of approximately $1.1 million, or 16%, when compared to the same period last year. This decline is mainly attributable to a $1.5 and $0.3 million revenue decrease in the United States and Europe consulting markets, respectively, offset by a gain in the Puerto Rico consulting business of approximately $0.7 million, of which $0.4 million are attributable to projects in Latin America that are managed from Puerto Rico. Other Company divisions sustained minor revenue gains/losses or remained constant, when compared to the same period last year. Net income was approximately $0.3 million, a decrease of $0.4 million when compared with the same period last year. Net income variance, when compared to the same period last year, is mainly attributable to the decline in revenue, offset by a reduction of business development and operational support expenses, and the effect of the effective income tax rates over income before tax. For the three months ended January 31, 2015, earnings per common share, basic and diluted, were $0.013 and $0.012, respectively, a decrease of $0.016 for both, when compared to the same period last year. The decrease is mainly attributable to the decrease in net income.

Pharma-Bio Serv, Inc. Announces Earnings Results for the Year Ended October 31, 2014

Pharma-Bio Serv, Inc. announced earnings results for the year ended October 31, 2014. For the year, the company reported total net revenues of $27.6 million for the year ended October 31, 2014, a decrease of approximately $5.5 million, or 16.7%, when compared to the same period last year. The revenue decrease is mainly attributable to a decline from consulting projects in the United States and Europe. Net income for year ended October 31, 2014 was approximately $2.4 million, a decrease of $2.5 million when compared to the same period last year. The decrease was mainly attributable to the decline in revenue, the increase in selling general and administrative expenses, and operations investments incurred to diversify markets, services and customer base, and the impact of the effective income tax rates (including Puerto Rico favorable tax grants) over income before tax.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBSV:US $0.94 USD 0.00

PBSV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PBSV.
View Industry Companies
 

Industry Analysis

PBSV

Industry Average

Valuation PBSV Industry Range
Price/Earnings 10.7x
Price/Sales 0.9x
Price/Book 1.0x
Price/Cash Flow 10.5x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMA-BIO SERV INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.